Press release
Peptide Therapeutics Market Forecast To 2026 With Key Companies Profile, Supply, Demand, Cost Structure, And SWOT Analysis
Peptide Therapeutics Market
Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/1837
Furthermore, increasing development are in progress to extend the half-life period of peptide drugs; to improve the oral bioavailability of peptide therapeutics and to enhance the Central Nervous System (CNS) availability of peptide drugs through nanoparticle delivery in the indications such as Alzheimer’s disease and stroke.
Market Dynamics
Market players are engaged in developing novel and innovative peptide therapeutics drugs in order to offer tailored solution to target patient by increasing biocompatibility and potent therapeutic effects. Increasing prevalence of cancer and diabetes mellitus is projected to drive growth of the peptide therapeutics market over the forecast period. Also, clinical development in the field of peptide reflects it as an effective tool for molecular pharmacology.
The global peptide therapeutics market size was valued at US$ 22,071.5 Mn in 2017 and is expected to witness a CAGR of 9.1% over the forecast period (2018 – 2026).
Global Key Players:
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Takeda Pharmaceuticals Co. Ltd., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Encycle Therapeutics, Inc., CirclePharma, Inc., Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., among others.
Detailed Segmentation:
Global Peptide Therapeutics Market, By Type:
Branded Peptide
Generic Peptide
Global Peptide Therapeutics Market, By Application:
Cancer
Cardiovascular Disease
Metabolic Disease
Respiratory Disease
Infectious Disease
Others
Global Peptide Therapeutics Market, By Route of Administration:
Oral Administration
Parenteral Administration
Others
Global Peptide Therapeutics Market, By Geography:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1837
Increasing Research and Development (R&D) Activities in the Field of Peptide Therapeutics is Expected to Drive Peptide Therapeutics Market Growth
Increasing Research and Development (R&D) activities in the field of peptide therapeutics and regulatory approval to peptide derived drugs or products shows lucrative trend in the peptide therapeutics market. For instance, according to the Drug Discovery Today Journal data findings, in 2015, more than 60 U.S. Food and Drug Administration (FDA) approved peptide medicines are available in market with around 140 peptide drugs in clinical trials and more than 500 therapeutic peptides in preclinical development. Moreover, peptide therapeutics market is projected to witness significant growth over the forecasted period, owing to the increase in the development of novel peptide drugs. Glucagon-like peptide-1 (GPL-1) agonists, one of the novel peptide drug class commonly used indicated for the treatment of type 2 diabetes mellitus (T2DM).
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics Market Forecast To 2026 With Key Companies Profile, Supply, Demand, Cost Structure, And SWOT Analysis here
News-ID: 1851510 • Views: …
More Releases from Coherent Market Insight
Cervical Dysplasia Market Size Likely to be valued at US$ 784.8 Million by 2030, …
Cervical dysplasia, a condition characterized by abnormal cell changes in the cervix, is often linked to human papillomavirus (HPV) infection and smoking. It primarily affects women above the age of 30. However, it's crucial to note that cervical dysplasia is preventable, and regular cervical screening tests play a vital role in the early diagnosis of precancerous stages.
This overview focuses on the key factors associated with cervical dysplasia and highlights preventive…
High Potency Active Pharmaceutical Ingredients Market Size Likely to be valued a …
The global High Potency Active Pharmaceutical Ingredients market size is expected to reach USD 40.99 billion by 2030, registering a CAGR of 9.9% from 2023 to 2030, according to a new report by Coherent Market Insight Inc.
High potency active pharmaceutical ingredients (HPAPIs) encompass small-molecule compounds, biologics, and antibody-drug conjugates that play a crucial role in modern medicine. With their ability to precisely and selectively target diseased cells, HPAPIs have…
Virtual Rehabilitation and Telerehabilitation System Market is a rapidly growing …
The global virtual rehabilitation and telerehabilitation systems market is expected to exhibit a CAGR of 19.2% during the forecast period (2023-2030). Manufacturers are focused on development and launch of innovative rehabilitation devices, which is expected to drive the virtual rehabilitation and telerehabilitation systems market growth. For instance, in August 2019, Ekso Bionics Holdings launched its EksoNR, the next generation of its EksoGT robotic exoskeleton, developed for neurorehabilitation purposes.
The device is…
Single Cell Analysis Market 2023-2030 | Industry Insights | Future Trends | Boom …
Single cell analysis allows for the study of individual cells within a complex biological system, providing a more detailed and comprehensive understanding of cellular behavior and function. This technology has been instrumental in advancing research in various fields, including cancer biology, immunology, and neuroscience.
One of the key drivers of the single cell analysis market is the increasing demand for personalized medicine. As researchers gain a better understanding of individual cell…
More Releases for Peptide
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
There are two main types of products available in the customized peptide synthesis…
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected…
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,…
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future.
Click to Request a Sample:…
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market
Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug…
